Corcept Therapeutics

Associate Director, Patient Access Program

Redwood City, California, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess proven ability to independently lead strategic initiatives, manage competing priorities, and drive resolution of complex issues with minimal oversight. Demonstrated excellence in organizational leadership, time management, and the ability to pivot effectively in dynamic, fast-paced environments is required. A strategic thinking ability with a track record of shaping and executing operational plans aligned with organizational goals is necessary. Comfort navigating ambiguity and leading teams through change and evolving business needs is essential. Deep expertise in health insurance, including pharmacy benefits, Medicare Part D, prior authorization and appeals, and specialty drug reimbursement is required. A strong understanding of U.S. healthcare policy, regulatory frameworks, and compliance standards, with the ability to guide teams in adhering to these requirements, is crucial. In-depth knowledge of HIPAA and privacy regulations, with a commitment to maintaining the highest standards of patient confidentiality, is mandatory. Experience overseeing Adverse Event and Product Quality Complaint reporting processes in alignment with regulatory expectations is preferred. Willingness to travel for high-impact engagements is also a requirement.

Responsibilities

The Associate Director of the Endocrinology Patient Support Program (PSP) is responsible for ensuring patient access to Corcept’s endocrinology therapies by leading the case management team and overseeing day-to-day operations of the patient support program. This role involves facilitating patient support program objectives through setting, monitoring, and driving service goals. The Associate Director is responsible for the implementation and ongoing management of program business rules while continually identifying opportunities for program improvements in scope of services and efficiency of service delivery. Key duties include providing strategic direction and operational oversight for all case management patient support program activities, ensuring alignment with organizational goals and objectives. They will lead cross-functional collaboration with internal and external stakeholders to optimize patient support strategies and drive measurable outcomes. This role also involves driving case management team performance by providing coaching, development opportunities, and motivational leadership, fostering a high-performing and engaged team through regular feedback and performance monitoring. Overseeing the resolution of escalated or urgent patient and medical office inquiries related to access and reimbursement, ensuring timely and effective solutions that enhance customer satisfaction, is a core responsibility. Additionally, developing and implementing workforce management strategies, including volume forecasting, capacity planning, and proactive staffing assessments to ensure optimal resource allocation and service excellence, is part of the role.

Skills

Patient Access Programs
Case Management
Operational Oversight
Program Management
Cross-functional Collaboration
Endocrinology
Cortisol Modulators
Glucocorticoid Receptor (GR)
Strategic Direction
Service Goals
Business Rules
Process Improvement

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters
1998Year Founded
$39.7MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options
Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.
Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.
Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.
Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.
Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.
Advancements in drug delivery systems could enhance Corcept's product efficacy.
The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI